900148
Iron oxide (II,III), nanoparticles
30 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352303
NACRES:
NA.23
Recommended Products
form
dispersion
nanoparticles
Quality Level
packaging
pkg of 1 mL
storage condition
do not freeze
concentration
1 mg/mL in H2O
avg. part. size
30 nm (TEM)
functional group
streptavidin
storage temp.
2-8°C
Looking for similar products? Visit Product Comparison Guide
General description
Recent docking studies highlight the potential interaction of iron oxide (II,III) nanoparticles (IONPs) with the SARS-CoV-2 spike protein receptor binding domain. This may target viral entry in host cells and also render virions inactive.
Application
IONPs may be used in the nanoparticle preparation for evaluation of their antiviral property against H1N1 influenza A virus.
Iron oxide nanoparticles exhibit biocompatibility and non-toxicity and are used as magnetic resonance imaging contrast agents, gene carriers for gene therapy, therapeutic agents for hyperthermia-based cancer treatment, magnetic sensing probes for in vivo diagnostics and for target specific drug delivery.
Legal Information
Product of Ocean Nanotech, LLC.
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
A Molecular Docking Study Repurposes FDA Approved Iron Oxide Nanoparticles to Treat and Control COVID-19 Infection
Abo-Zeid Y, et al.
European Journal of Pharmaceutical Sciences, 105465-105465 (2020)
Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus
Kumar R, et al.
Journal of Infection and Chemotherapy, 25(5), 325-329 (2019)
Xianglong Hu et al.
Dalton transactions (Cambridge, England : 2003), 44(9), 3904-3922 (2015-01-13)
Responsive polymeric assemblies and hybrid superstructures fabricated from stimuli-sensitive polymers and inorganic nanoparticles (NPs) have been the subject of extensive investigations during the past few decades due to their distinct advantages such as an improved water solubility, stimuli-responsiveness, excellent biocompatibility
Joan Estelrich et al.
International journal of molecular sciences, 16(4), 8070-8101 (2015-04-14)
In this review, we discuss the recent advances in and problems with the use of magnetically-guided and magnetically-responsive nanoparticles in drug delivery and magnetofection. In magnetically-guided nanoparticles, a constant external magnetic field is used to transport magnetic nanoparticles loaded with
Jin Xie et al.
Theranostics, 2, 122-124 (2012-01-31)
This theme issue provides a timely collection of studies on magnetic nanoparticle-based imaging, bio-sensing, therapy and/or their combinations.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service